Immunogene therapy of murine fibrosarcoma using IL-15 gene with high translation efficiency

European Journal of Immunology

Volumn 29, Issue 5, 1999, Pages 1532-1542

  Kimura, Keiko ^a   Nishimura, Hitoshi ^a   Hirose, Kenji ^a   Matsuguchi, Tetsuya ^a   Nimura, Yuji ^a   Yoshikai, Yasunobu ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Alternative cDNA; Gene therapy; IL 15; Meth A tumor

Indexed keywords

COMPLEMENTARY DNA; INTERLEUKIN 15; MESSENGER RNA; OKT 4; OKT 8;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; EXON; EXPRESSION VECTOR; FIBROSARCOMA; GENE THERAPY; IMMUNOGENETICS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA TRANSLATION; TUMOR GROWTH;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; FIBROSARCOMA; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOTHERAPY; INTERLEUKIN-15; MALE; MICE; MICE, INBRED BALB C; PROTEIN BIOSYNTHESIS; TRANSFECTION;

EID: 0032950172     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199905)29:05<1532::AID-IMMU1532>3.0.CO;2-Z     Document Type: Article

References (56)

1. Zier, K., Gansbacher, B. and Salvadori, S., Prevention abnormalities in signal; transduction of T cells in cancer: the promise of cytokine gene therapy. Immunol Today 1996. 17: 39-45.
2. Howard, B., Burrascano, M., McCallister, T., Chong, K., Gangavalli, R., Severinsson, L., Jolly, D. J., Darrow, T., Vervaert, C. and Abdel-Wahab, Z., Retrovirus-mediated gene transfer of the human gamma-IFN gene: a therapy for cancer. Ann. N Y Acad. Sci. 1994. 716: 167-187.
3. Rosenthal, F. M., Cronin, K., Bannerji, R., Golde, D. W. and Gansbacher, B., Augmention of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNA. Blood 1994. 83: 1289-1298.
4. + T cells against the wild-type tumor: correlation with antigen presentation capability. J. Exp. Med 1992. 175: 1423-1431.
5. Armstrong, C. A., Botella, R., Galloway, T. H., Murray, N., Kramp, J. M., Song, I.S. and Ansel, J. C., Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells. Cancer Res. 1996. 56: 2191-2198.
6. Karp, S. E., Farber, A., Salo, J. C., Hwu, P., Jaffe, G., Asher, A. L., Shiloni, E., Restifo, N. P., Mule, J. J. and Rosenberg, S. A., Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factor. J. Immunol. 1993. 150: 896-908.
7. Mackensen, A., Lindemann, A. and Mertelsmann, R. J., Immunostimulatory cytokines in somatic cells and gene therapy of cancer. Cytokine Growth Factor Rev. 1997. 8: 119-128.
8. Tanaka, F., Abe, M., Akiyoshi, T., Nomura, T., Sugimachi, K., Kishimoto, T., Suzuki, T. and Okada, M., The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector. Cancer Res. 1997. 57: 1335-1343.
9. McBride, W. H., Thacker, J. D., Comora, S., Economou, J. S., Kelley, D., Hogge, D., Dubinett, S. M. and Dougherty, G. J., Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity. Cancer Res. 1992. 52: 3931-3937.
10. Tahara, H., Zitvogel, L., Storkus, W. J., Zeh, H. J. 3rd, McKinney, T. G., Schreiber, R. D., Gubler, U., Robbins, P. D., Lotze, M. T., Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol. 1995. 154: 6466-6474.
11. Bannerji, R., Arroyo, C. D., Cordon-Cardo, C. and Gilboa, E., The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity. J. Immunol. 1994. 152: 2324-2332.
12. + T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J. Immunol. 1992. 149: 3627-3635.
13. Fearon, E. R., Pardoll, D. M., Itaya, T., Golumbek, P., Levitsky, H. I., Simons, J. W., Karasuyama, H., Vogelstein, B. and Frost, P., Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 1990. 60: 397-403.
14. Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M. A., Ahdieh, M., Johnson, L., Alderson, M. R., Watson, J. D., Anderson, D. M. and Giri, J. G., Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 1994. 264: 965-968.
15. Bamford, R. N., Grant, A. J., Burton, J. D., Peters, C., Kury, G., Goldman, C. K., Brennan, J., Roessler, J. and Waldmann, T. A., The interleukin (IL) 2 receptor β chain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA 1994. 91: 4940-4944.
16. Giri, J. G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K., Kumaki, S., Namen, A., Park, L. S., Cosman, D. and Anderson, D., Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO. J. 1994. 13: 2822-2830.
17. Carson, W. E., Ross, M. E., Baiocchi, R. A., Marien, M. J., Boiani, N., Grabstein, K. and Caligiuri, M. A., Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J. Clin. Invest. 1995. 96: 2578-2582.
18. Armitage, R. J., Macduff, B. M., Eisenman, J., Paxton, R. and Grabstein, K. H., IL-15 has stimulatory activity for the induction of cell proliferation and differentiation. J. Immunol. 1995. 154: 483-490.
19. Nishimura, H., Hiromatsu, K., Kobayashi, N., Grabstein, K. H., Paxton, R., Sugamura, K., Bluestone, J. A. and Yoshikai, Y., IL-15 is a novel growth factor for murine gamma delta T cells induced by Salmonella infection. J. Immunol. 1996. 156: 663-669.
20. Inagaki-Ohara, K., Nishimura, H., Mitani, A. and Yoshikai, Y., Interleukin-15 preferentially promotes the growth of intestinal intraepitherial lymphocytes bearing γδ T cell receptor in mice. Eur. J. Immunol. 1997. 27: 2885-2891.
21. + cell development. J. Immunol. 1997. 159: 5931-5935.
22. Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Grabstein, K. and Caligiuri, M. A., Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 1994. 180: 1395-1403.
23. Gamero, A. M., Ussery, D., Reintgen, D. S., Puleo, C. A. and Djeu, J. Y., Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism. Cancer Res. 1995. 55: 4988-4994.
24. Takeuchi, E., Yanagawa, H., Yano, S., Haku, T. and Sone, S., Induction by interleukin-15 of human killer cell activity against lung cancer cell lines and its regulatory mechanisms, Jan. J. Cancer Res. 1996. 87: 1251-1258.
25. Evans, R., Fuller, J. A., Christianson, G., Krupke, D. M. and Troutt, A. B., IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumorbearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations. Cell. Immunol. 1997. 179: 66-73.
26. Munger, W., Quinn, S., Jeyaseelan Sr, D. R., Torley, L. W., Grabstein, K. H., Eisenmann, J., Paxton, R., Cox, T., Wick, M. M. and Kerwar, S. S., Studies evaluating the antitumor activity and toxicity of interleukin-15, a new T cell growth factor: comparison with interleukin-2. Cell. Immunol. 1995. 165: 289-293.
27. Tagaya, Y., Bamford, R. N., DeFilippis, A. P. and Waldmann, T. A., IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 1996. 4: 329-336.
28. Onu, A., Pohl, T., Krause, H. and Bulfone-Paus, S., Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. J. Immunol. 1997. 158: 255-262.
29. Bamford, R. N., Battiata, A. P., Burton, J. D., Sharma, H. and Waldmann, T. A., Interleukin (IL) 15/IL-T production by the adult T-cell leukemia cell line Hut-102 is associated with a human T-cell lymphotrophic virus type I R region/IL-15 fusion message that lacks many upstream AUGs that normally attenuate IL-15 mRNA translation. Proc. Natl. Acad. Sci. USA 1996. 93: 2897-2902.
30. Bamford, R. N., Battiata, A. P. and Waldmann, T. A., IL-15: The role of translational regulation in their expression. J. Leukoc. Biol. 1996. 54: 476-480.
31. Mezza, R., Gaggero, A., Neglia, F., Basso, S., Soforzini, S., Pereno, R., Azzarone, B. and Ferrini, S., Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides. Eur. J. Immunol. 1997. 27: 1049-1054.
32. Bamford, R. N., DeFilippis, A. P., Azimi, N., Kurys, G. and Waldmann, T. A., The 5′ untranslated region, signal peptide, and the coding sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control. J. Immunol. 1998. 160: 4418-4426.
33. Tagaya, Y., Kurys, G., Thies, T. A., Losi, J. M., Azimi, N., Hanover, J. A., Bamford, R. N. and Waldmann, T. A., Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc. Natl. Acad. Sci. USA 1997. 94: 14444-14449.
34. Meazza, R., Verdiani, S., Biassoni, R., Coppolecchia, M., Gaggero, A., Orengo, A. M., Colombo, M. P., Azzarone, B. and Ferrini, S., Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines. Oncogene 1996. 12: 2187-2192.
35. Nishimura, H., Washizu, J., Nakamura, N., Enomoto, A. and Yoshikai, Y., Translational efficiency is up-regulated by alternative exon in murine IL-15 mRNA. J. Immunol. 1998. 160: 936-942.
36. Suzuki, H., Kundig, T. M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., Schmits, R., Simard, J. J. L., Ohashi, P. S., Griesser, H., Taniguchi, T., Paige, C. and Mak, T. W., Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 1995. 268: 1472-1476.
37. Suzuki, H., Duncan, G. S., Takimoto, H. and Mak, T. W., Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain. J. Exp. Med. 1997. 185: 499-505.
38. Tanaka, T., Kitamura, F., Nagasaka, Y., Kuida, K., Suwa, H. and Miyasaka, M., Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor beta chain monoclonal antibody in mice. J. Exp. Med. 1993. 178: 1103-1107.
39. Ogasawara, K., Hida, S., Azimi, N., Tagaya, Y., Sato, T., Yokochi-Fukuda, T., Waldmann, T. A., Taniguchi, T., and Taki, S., Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 1998. 391: 700-703.
40. Chouaib, S., Asselin-Paturel, C., Mami-Chouaib, F., Caignard, A. and Blay, J. Y., The host-tumor immune conflict: from immunosuppression to resistance and destruction. Immunol. Today 1997. 18: 493-497.
41. Mizoguchi, H., O'Shea, J. J., Longo, D. L., Loeffler, C. M., McVicar, D. W., Ochoa, A. C., Alterations in signal transduction molecules in T lymphocytes from tumorbearing mice. Science 1992. 258: 1795-1798.
42. lck in T-cells infiltrating human renal cell carcinoma. Cancer Res. 1993. 53: 5613-5616.
43. Nakagomi, H., Petersson, M., Magnusson, I., Juhlin, C., Matsuda, M., Mellstedt, H., Taupin, J. L., Vivier, E., Anderson, P. and Kiessling, R., Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res. 1993. 53: 5610-5612.
44. Salvadori, S. and Zier, K., Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2. J. Immunol. 1996. 156: 2927-2932.
45. Salvadori, S., Gansbacher, B., Pizzimenti, A. M. and Zier, K. S., Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2-secreting tumors. J. Immunol. 1994. 153: 5176-5182.
46. Aoe, T., Okamoto, Y. and Saito, T., Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex. J. Exp. Med. 1995. 181: 1881-1886.
47. Ono, S., Ohno, H., Saito, T., Rapid turnover of the CD3 zeta chain independent of the TCR-CD3 complex in normal T cells. Immunity 1995. 2: 639-644.
48. Witthuhn, B. A., Silvennoinen, O., Miura, O., Lai, K. S., Cwik, C., Liu, E. T., Ihle, J. N., Involvement of the Jak-3 Janus kinase in signalling by interleukin 2 and 4 in lymphoid and myeloid cells. Nature 1994. 370: 153-157.
49. Johnston, J. A., Kawamura, M., Kirken, R. A., Chen, Y. Q., Blake, T. B., Shibuya, K., Ortaldo, J. R., McVicar, D. W. and O'Shea, J. J., Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 1994. 370: 151-153.
50. Pazdrak, K., Justement, L. and Alam, R., Mechanism of inhibition of eosinophil activation by transforming growth factor-beta. Inhibition of Lyn, MAP, Jak2 kinases and STAT1 nuclear factor. J. Immunol. 1995. 155: 4454-4458.
51. Garcia, V. E., Jullien, D., Song, M., Uyemura, K., Shuai, K., Morita, C. T. and Modlin, R. I., IL-15 enhances the response of human γδ T cells to nonpeptide microbial antigens. J. Immunol. 1998. 160: 4322-4329.
52. McInnes, I. B., Mughales, J., Field, M., Leung, B. P., Huang, F. P., Dixon, R., Sturrock, R. D., Wilkinson, P. C. and Liew, F. Y., The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nature Med. 1996. 2: 175-182.
53. Nieto, M., del Pozo, M. A. and Sanchez-Madris, F., Interleukin-15 induces adhesion receptor redistribution in T lymphocytes. Eur. J. Immunol. 1996. 26: 1302-1307.
54. Alleva, D. G., Kaser, S. B., Monroy, M. A., Fenton, M. J. and Beller, D. I., IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J. Immunol. 1997. 159: 2941-2951.
55. Anderson, D. M., Johnson, L., Glaccum, M. B., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Valentine, V., Kirstein, M. N., Shapiro, D. N., Morris, S. W., Grabstein, K. H. and Caligiuri, M. A., Chromosomal assignment and genomic structure of IL15. Genomics 1995. 25: 701-706.
56. Chomczynski, P. and Sacchi, N., Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987. 162: 156-159.